The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The P-glycoprotein multidrug transporter
Abstract
Pgp (P-glycoprotein) (ABCB1) is an ATP-powered efflux pump which can transport hundreds of structurally unrelated hydrophobic amphipathic compounds, including therapeutic drugs, peptides and lipid-like compounds. This 170 kDa polypeptide plays a crucial physiological role in protecting tissues from toxic xenobiotics and endogenous metabolites, and also affects the uptake and distribution of many clinically important drugs. It forms a major component of the blood–brain barrier and restricts the uptake of drugs from the intestine. The protein is also expressed in many human cancers, where it probably contributes to resistance to chemotherapy treatment. Many chemical modulators have been identified that block the action of Pgp, and may have clinical applications in improving drug delivery and treating cancer. Pgp substrates are generally lipid-soluble, and partition into the membrane before the transporter expels them into the aqueous phase, much like a ‘hydrophobic vacuum cleaner’. The transporter may also act as a ‘flippase’, moving its substrates from the inner to the outer membrane leaflet. An X-ray crystal structure shows that drugs interact with Pgp within the transmembrane regions by fitting into a large flexible binding pocket, which can accommodate several substrate molecules simultaneously. The nucleotide-binding domains of Pgp appear to hydrolyse ATP in an alternating manner; however, it is still not clear whether transport is driven by ATP hydrolysis or ATP binding. Details of the steps involved in the drug-transport process, and how it is coupled to ATP hydrolysis, remain the object of intensive study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Smit, J. J. M., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,456
Structure of a bacterial multidrug ABC transporter
Dawson, R. J. P., & Locher, K. P. (2006) · Nature · doi:10.1038/nature05155 · Cited by 1,279
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Self-citationP-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Smith, P. C., Karpowich, N., Millen, L., Moody, J. E., Rosen, J., Thomas, P. J., & Hunt, J. F. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00576-2 · Cited by 773
Flexibility in the ABC transporter MsbA: Alternating access with a twist
Ward, A., Reyes, C. L., Yu, J., Roth, C. B., & Chang, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709388104 · Cited by 771
The ATP switch model for ABC transporters
Higgins, C. F., & Linton, K. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb836 · Cited by 748
Is the multidrug transporter a flippase?
Higgins, C. F., & Gottesman, M. M. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90419-a · Cited by 722
Human P-glycoprotein transports cyclosporin A and FK506.
Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., & Komano, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53221-x · Cited by 684
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
Zhou, S.-F. (2008) · Xenobiotica · doi:10.1080/00498250701867889 · Cited by 599
Phosphatidylcholine translocase: A physiological role for the mdr2 gene
Ruetz, S. (1994) · Cell · doi:10.1016/0092-8674(94)90446-4 · Cited by 599
ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
Eckford, P. D. W., & Sharom, F. J. (2009) · Chemical Reviews · doi:10.1021/cr9000226 · Cited by 597
Self-citationPositively Cooperative Sites for Drug Transport by P‐Glycoprotein with Distinct Drug Specificities
Shapiro, A. B., & Ling, V. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00130.x · Cited by 475
The catalytic cycle of P‐glycoprotein
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01345-8 · Cited by 440
Choudhuri, S., & Klaassen, C. D. (2006) · International Journal of Toxicology · doi:10.1080/10915810600746023 · Cited by 415
Urbatsch, I. L., Sankaran, B., Weber, J., & Senior, A. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19383 · Cited by 363
Breedveld, P., Beijnen, J. H., & Schellens, J. H. M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.009 · Cited by 323
Multidrug Resistance Reversal Agents
Robert, J., & Jarry, C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030183a · Cited by 292
Borrelli, F., & Izzo, A. A. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9146-8 · Cited by 288
Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)
Oude Elferink, R. P. J., & Paulusma, C. C. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0062-9 · Cited by 282
Sharom, F. J., Yu, X., & Doige, C. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80510-9 · Cited by 256
Self-citationStieger, B., Meier, Y., & Meier, P. J. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0152-8 · Cited by 235
Reversal of multidrug resistance by surfactants
Woodcock, D., Linsenmeyer, M., Chojnowski, G., Kriegler, A., Nink, V, Webster, L., & Sawyer, W. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.217 · Cited by 233
P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct Groups
Scala, S., Akhmed, N., Rao, U. S., Paull, K., Lan, L.-B., Dickstein, B., Lee, J.-S., Elgemeie, G. H., Stein, W. D., & Bates, S. E. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.1024 · Cited by 229
Subunit interactions in ABC transporters: towards a functional architecture
Jones, P. (1999) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(99)00411-5 · Cited by 219
Alvarez, M., Paull, K., Monks, A., Hose, C., Lee, J. S., Weinstein, J., Grever, M., Bates, S., & Fojo, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117910 · Cited by 216
Janas, E., Hofacker, M., Chen, M., Gompf, S., van der Does, C., & Tampé, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301227200 · Cited by 167
The motor domains of ABC-transporters: What can structures tell us?
Oswald, C., Holland, I. B., & Schmitt, L. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-0031-4 · Cited by 164
Three-dimensional Structure of P-glycoprotein
Rosenberg, M. F., Callaghan, R., Modok, S., Higgins, C. F., & Ford, R. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410296200 · Cited by 163
Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors
Coley, H. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_15 · Cited by 160
Dantzig, A., Law, K., Cao, J., et al. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373903 · Cited by 156
Phospholipid Flippase Activity of the Reconstituted P-Glycoprotein Multidrug Transporter
Romsicki, Y., & Sharom, F. J. (2001) · Biochemistry · doi:10.1021/bi0024456 · Cited by 155
Self-citationLoo, T. W., Bartlett, M. C., & Clarke, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200484200 · Cited by 146
Chan, H. S. L., Deboer, G., Thiessen, J. J., et al. (1996) · PubMed · Cited by 138
ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?
Steinbach, D., & Legrand, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404692 · Cited by 127
Characterization of an Asymmetric Occluded State of P-glycoprotein with Two Bound Nucleotides
Siarheyeva, A., Liu, R., & Sharom, F. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047290 · Cited by 117
Self-citationSauna, Z. E., Kim, I., Nandigama, K., Kopp, S., Chiba, P., & Ambudkar, S. V. (2007) · Biochemistry · doi:10.1021/bi701385t · Cited by 109
Blockage of Drug Resistance In Vitro by Disulfiram, a Drug Used to Treat Alcoholism
Loo, T. W. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.898 · Cited by 108
Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor
Raggers, R. J., Vogels, I. M. C., & Gerrit van, M. E. E. R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570859 · Cited by 105
ABC transporters in the balance: is there a role in multidrug resistance?
Polgár, O., & Bates, S. E. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330241 · Cited by 104
Expression and Function of P-Glycoprotein in Normal Tissues: Effect on Pharmacokinetics
Štaud, F., Čečková, M., Mičuda, S., & Pávek, P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_10 · Cited by 104
The translocation mechanism of P‐glycoprotein
Callaghan, R., Ford, R. C., & Kerr, I. D. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.11.083 · Cited by 102
The Occluded Nucleotide Conformation of P-Glycoprotein
Tombline, G., & Senior, A. E. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-9498-4 · Cited by 53
Eckford, P. D. W., & Sharom, F. J. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-196 · Cited by 48
Self-citationMultidrug Resistance Protein: P‐Glycoprotein
Sharom, F. J. (2006) · doi:10.1002/9780470140505.ch10 · Cited by 27
Self-citation
Cited by
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866
Mechanistic diversity in ATP-binding cassette (ABC) transporters.
Locher, K. P. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3216 · Cited by 804
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
P-glycoprotein Inhibition for Optimal Drug Delivery
Amin, M. L. (2013) · Drug Target Insights · doi:10.4137/dti.s12519 · Cited by 624
Metadata
- Authors
- Sharom, F. J.
- Venue
- Essays in Biochemistry
- Publisher
- Portland Press Ltd.
- Published
- 2011-09-07
- Volume
- 50
- Issue
- 1
- Pages
- 161-178
- ISSN
- 0071-1365 (ISSN-L)
- 1744-1358
- OpenAlex
- W2035248522
- Cited by
- 509
- References
- 51
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.